cyclooxygenase inhibitors

Preferred Label : cyclooxygenase inhibitors;

MeSH definition : Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.;

MeSH synonym : prostaglandin synthesis antagonists; inhibitors, cyclo oxygenase; inhibitors, prostaglandin synthase; inhibitors, prostaglandin-endoperoxide synthase; inhibitors, cyclo-oxygenase; inhibitors, cyclooxygenase; antagonists, prostaglandin synthesis; inhibitors, prostaglandin endoperoxide synthase; prostaglandin endoperoxide synthase inhibitors; prostaglandin synthase inhibitors; cyclo-oxygenase inhibitors; cyclo oxygenase inhibitors; Cyclo-Oxygenase Inhibitor; Cyclo Oxygenase Inhibitor; Inhibitor, Cyclo-Oxygenase; Prostaglandin Synthesis Antagonist; Antagonist, Prostaglandin Synthesis; Synthesis Antagonist, Prostaglandin; Prostaglandin Endoperoxide Synthase Inhibitor; Prostaglandin Synthase Inhibitor; Inhibitor, Prostaglandin Synthase; Synthase Inhibitor, Prostaglandin; Cyclooxygenase Inhibitor; Inhibitor, Cyclooxygenase;

MeSH annotation : DF: CYCLOOXYGENASE INHIB;

Wikipedia link : https://en.wikipedia.org/wiki/Cyclooxygenase inhibitors;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D016861;

UMLS CUI

C0085387;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Prostaglandin-endoperoxide synthase inhibitor (disposition) [SNOMED CT concept]
- Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Cyclooxygenase Inhibitor [NCIt concept]
Indexing information
- (Z)-2-amino-1,5-dihydro-1-methyl-5-(4-(mesyl)benzylidene)-4H-imidazol-4-one mesilate [MeSH Supplementary Concept]
- 1,5-diphenyl-1H-pyrazole-3-carbohydrazide [MeSH Supplementary Concept]
- 3-(5-chlorofuran-2-yl)-4-phenyl-5-(trifluoromethyl)isoxazole [MeSH Supplementary Concept]
- 3-amino-6-(3-aminopropyl)-5,6-dihydro-5,11-dioxo-11H-indeno(1,2-c)isoquinoline [MeSH Supplementary Concept]
- 3-methoxy-1,5-bis(4-methoxyphenyl)-1H-1,2,4-triazole [MeSH Supplementary Concept]
- 4'-(bromoacetamido)-N-(2,3-dimethylphenyl)anthranilic acid [MeSH Supplementary Concept]
- 4'-(bromoacetamido)-benzyl-indomethacin [MeSH Supplementary Concept]
- 4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate [MeSH Supplementary Concept]
- 5,6-bis(nitrooxy)hexyl 2-(6-methoxynaphthalen-2-yl)propanoate [MeSH Supplementary Concept]
- 5-((5-bromo-1H-indol-3-yl)methylene)-3-(4-chlorobenzyl)thiazolidine-2,4-dione [MeSH Supplementary Concept]
- 5-propyl-3-(4-propylphenoxy)benzene-1,2-diol [MeSH Supplementary Concept]
- 6-acetoxy-7-hydroxyroyleanone [MeSH Supplementary Concept]
- CHP1002 [MeSH Supplementary Concept]
- KYKZL-1 compound [MeSH Supplementary Concept]
- UP446 [MeSH Supplementary Concept]
- camphorataimide B [MeSH Supplementary Concept]
- crassarine F [MeSH Supplementary Concept]
- crassarine H [MeSH Supplementary Concept]
- ethyl 4-(benzyloxy)-3-((3-(4-methoxytetrahydro-2H-pyran-4-yl)phenyl)methylsulfonamido)benzoate [MeSH Supplementary Concept]
- prostaglandin synthase inhibitor, endogenous [MeSH Supplementary Concept]
- salicylamide [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- cyclooxygenase 1 [MeSH Descriptor]
- prostaglandin-endoperoxide synthases [MeSH Descriptor]
Record concept(s)
- cyclooxygenase inhibitors [MeSH concept]
See also
- anti-inflammatory agents, non-steroidal [MeSH Descriptor]
- prostaglandin antagonists [MeSH Descriptor]
See also (suggested by CISMeF)
- antipyretics [MeSH Descriptor]
- prostaglandin-endoperoxide synthases [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine [MeSH Supplementary Concept]
- 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole [MeSH Supplementary Concept]
- 1-(4-chlorobenzoyl)-3-(2-(1H-imidazol-1-yl)-2-oxoethyl)-5-methoxy-2-methyl-1H-indole [MeSH Supplementary Concept]
- 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine [MeSH Descriptor]
- 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide [MeSH Supplementary Concept]
- 6-ethoxy-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-one [MeSH Supplementary Concept]
- 7-methoxy-alpha-methyl-2-naphthaleneacetic acid [MeSH Supplementary Concept]
- DuP 697 [MeSH Supplementary Concept]
- Ethonium [MeSH Supplementary Concept]
- L 745337 [MeSH Supplementary Concept]
- L 778736 [MeSH Supplementary Concept]
- LQFM-091 [MeSH Supplementary Concept]
- Magnesium Salicylate [MeSH Supplementary Concept]
- N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide [MeSH Supplementary Concept]
- N-succinimidyl-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate [MeSH Supplementary Concept]
- Oxaprozin [MeSH Descriptor]
- SC 299 [MeSH Supplementary Concept]
- SC 560 [MeSH Supplementary Concept]
- Ursolic Acid [MeSH Descriptor]
- acetylsalicylic acid lysinate [MeSH Supplementary Concept]
- aspirin [MeSH Descriptor]
- deracoxib [MeSH Supplementary Concept]
- diclofenac [MeSH Descriptor]
- diflunisal [MeSH Descriptor]
- ebselen [MeSH Supplementary Concept]
- fenbufen [MeSH Supplementary Concept]
- fenoprofen [MeSH Descriptor]
- flosulide [MeSH Supplementary Concept]
- flurbiprofen [MeSH Descriptor]
- ibuprofen [MeSH Descriptor]
- indobufen [MeSH Supplementary Concept]
- indomethacin [MeSH Descriptor]
- indoprofen [MeSH Descriptor]
- ketoprofen [MeSH Descriptor]
- ketorolac [MeSH Descriptor]
- ketorolac tromethamine [MeSH Descriptor]
- licofelone [MeSH Supplementary Concept]
- masoprocol [MeSH Descriptor]
- meclofenamic acid [MeSH Descriptor]
- mefenamic acid [MeSH Descriptor]
- mofezolac [MeSH Supplementary Concept]
- naproxen [MeSH Descriptor]
- niflumic acid [MeSH Descriptor]
- nimesulide [MeSH Supplementary Concept]
- phenidone [MeSH Supplementary Concept]
- piroxicam [MeSH Descriptor]
- proquazone [MeSH Supplementary Concept]
- salicin [MeSH Supplementary Concept]
- salicylates [MeSH Descriptor]
- sinapaldehyde [MeSH Supplementary Concept]
- sodium salicylate [MeSH Descriptor]
- sulindac [MeSH Descriptor]
- sulindac sulfone [MeSH Supplementary Concept]
- suprofen [MeSH Descriptor]
- tenidap [MeSH Supplementary Concept]
- tenoxicam [MeSH Supplementary Concept]
- tolmetin [MeSH Descriptor]
- ursolic acid [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Cyclooxygenase Inhibitor [NCIt concept]
- Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients